Introduction to Direct-to-Consumer Genetic Testing

Slides:

Advertisements

Similar presentations

©2007 RALPH SNYDERMAN Third Annual Prospective Health Care Conference "Where are We Now?" Ralph Snyderman, MD Chancellor Emeritus, Duke University November.

Advertisements

Direct to Consumer Testing Issues. Types of tests being sold Diagnostic tests – identify specific conditions Carrier testing - identify those who carry.

Human Genetics Overview.

What Do Toxicologists Do?

Clinical Genotyping and Personalized Medicine Michael D. Kane, PhD (1) Associate Professor of Bioinformatics (2) University Faculty Scholar (3) Chair of.

Walgreens Genetic ‘Spit Kit’ Debate Rhonda Knapp Waunakee High School Biotech: Beyond the Basics June 2010.

What is personal genetics? What might it mean for me, my family and society? Personal Genetics Education Project (pgEd) Harvard Medical School

Georgia Wiesner, MD CREC June 20, GATACAATGCATCATATG TATCAGATGCAATATATC ATTGTATCATGTATCATG TATCATGTATCATGTATC ATGTATCATGTCTCCAGA TGCTATGGATCTTATGTA.

1 PhRMA Guiding Principles - DTC About Prescription Medicines.

Prospective Evaluation of B-type Natriuretic Peptide Concentrations and the Risk of Type 2 Diabetes in Women B.M. Everett, N. Cook, D.I. Chasman, M.C.

FDAAA – Report on DTC Advertising Kristin Davis, J.D. Deputy Director, Division of Drug Marketing, Advertising, and Communications Office of Medical Policy,

Clinical Research and Outcomes Registry Workshop Creating an Informed Consent Form Daniel Ford, MD, MPH Joseph Carrese, MD.

Regulatory Guidance for Genetic Testing. Three Specific Areas Laboratory tests Results of genetic testing – Clinical – Research GenomeWide Association.

Familial coronary artery disease Paul Brennan Clinical Director Northern Genetics Service Newcastle Hospitals NHS Foundation Trust North East and North.

Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Causal Assessment of Serum Urate Levels in Cardiometabolic.

Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.

Introduction. Practical Perspectives in the Surgical Management of Parkinson Disease: LCIG.

Nucleotide variation in the human genome

Patient Focused Drug Development An FDA Perspective

Partitioning of genomic variance using prior biological information

Pharmacogenetics and New Drug Discovery

Genetics of common complex diseases: a view from Iceland

Global Variation in Copy Number in the Human Genome

X Chromosome Inactivation

Familial Chylomicronemia Syndrome

Timely Diagnosis of Gastroenteritis: Implications for Patients and Public Health.

The Future of Osteoporosis: Improving Care Along the Way

SAVOR-TIMI 53 Summary SAVOR-TIMI 53: Primary End Point of CV Death, MI, Ischemic Stroke.

Introduction to Biosimilars

Chronic Hepatitis C Virus Infection

MS Highlights From the 2017 Annual Neurology Meeting

HCV: Who Should We Screen and Why?

Title of the Poster Authors Affiliation / Organization 1. Introduction

Medical Practices as Small Business:

Cognition and the Older Driver

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

Epidemiology 101 Epidemiology is the study of the distribution and determinants of health-related states in populations Study design is a key component.

Amyloid Imaging for Alzheimer's Disease in Practice

Federal Food Drug and Cosmetic Act 1938

Direct-To-Consumer Genetic Testing

Surveying the Safety of NOACs in the Real World

Abbreviated Protocols for Breast Cancer Screening

Chronic Idiopathic Urticaria

Program Goals. The Role of Chemotherapy in Improving Quality of Life in Advanced NSCLC.

Counseling Patients About Germline BRCA Mutations

Postpartum Depression

Multidisciplinary Perspectives on Interstitial Lung Diseases

Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.

OTC NSAID Use in Patients With OA and CV Disease

Professional Organizations

Case: A 28-Year-Old Man. When a 5-ASA Agent No Longer Maintains Remission in a Patient With Ulcerative Colitis.

Impactful Data in TD That Can Guide Treatment Decisions

Assessing Bias 1.

Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.

Scientific Update.

Implications of Emerging Treatments for Beta-Thalassemia

Figure 2 Association between coronary artery disease polygenic risk score and the presence of migraine Results are given as odds ratios with 95% confidence.

Figure 3 Mendelian randomization (MR) using a genetic

Challenges in Interpreting Multivariable Mendelian Randomization: Might “Good Cholesterol” Be Good After All? Michael V. Holmes, George Davey Smith

Elliott P, et al. JAMA 2009;302:37-48.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Neurol. doi: /nrneurol

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Practical Strategies for Getting Patients With Diabetes to Lipid Goal

Volume 379, Issue 9822, Pages (March 2012)

Volume 377, Issue 9766, Pages (February 2011)

Title Introduction: Discussion & Conclusion: Methods & Results:

Importance of Early Diagnosis and Management in SMA

Selective Immunomodulation in MS

A Fresh Perspective on Hypoactive Sexual Desire Disorder

Presentation transcript:

Introduction to Direct-to-Consumer Genetic Testing

Summary of Important Genetic Terms

Human Genome

Single Nucleotide Polymorphisms (SNPs)

SNPs (cont)

Complex Diseases

Mendelian Diseases

DTC Genetic Testing Options

Potential Risks With DTC Genetic Testing

Motivations for DTC Genetic Testing

DTC Genetic Testing: What Clinicians Need to Know

What Is DTC Genetic Testing?

Scope of DTC Genetic Testing

History of DTC Genetic Testing

FDA-Authorized DTC Genetic Tests

Evaluating DTC Genetic Tests

DTC Genetic Testing Efficacy

Platforms for Detecting Variants

DTC Genetic Test Interpretation

DTC Genetic Testing: What Clinicians Need to Know (cont)

Federal Regulation of Genetic Testing

DTC Genetic Testing Safety

Impact on Health Care

Conclusions

Abbreviations